Sarepta Therapeutics, Inc.·4

Dec 18, 8:05 PM ET

Estepan Ian Michael 4

4 · Sarepta Therapeutics, Inc. · Filed Dec 18, 2025

Insider Transaction Report

Form 4
Period: 2025-12-16
Estepan Ian Michael
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2025-12-16$22.31/sh13,187$294,202193,300 total
Footnotes (2)
  • [F1]Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.35 to 22.29, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4